The $113.7M modification adds to Leidos's backlog and confirms a strong relationship with HHS/NCI. Traders should monitor for additional task orders under this IDIQ vehicle and any future earnings calls that may provide updated revenue guidance reflecting this award.
How the stock moved after the report
⚠ Clustered BULLISH VIEWSTOCK BELOW ENTRY AT T+20- T+0 · Sep 1 $138.73entry
- T+1 · 3mo ago −3.88%α −4.32% · $133.35
- T+5 · 2mo ago −7.93%α −8.01% · $127.73
- T+20 · 7w ago −12.18%α −12.54% · $121.83
- T+53 · todayOpen
- T+60 · in 8d Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings (LDOS), received a $113.7M modification to its NCI operational task order from the Department of Health and Human Services. This is a material contract action for a key federal customer, reinforcing Leidos's position in health IT and biomedical research services.
Key Financial Metrics
Contract history
Every action SecBot has tracked on this contract, newest first; latest action 2026-09-30. Each amount is that action's figure: obligated by the action, the announced value, or for an award total, the award's value to date.
- 2026-09-30 Modification $342.2Mobligated Mod P00014 · USAspending
- 2026-08-31 Modification(this report) $113.7Mobligated Mod P00011 · USAspending
- 2026-08-18 Modification $29.5Mobligated Mod P00010 · USAspending
Key Facts
- Leidos Biomedical Research Inc. received a $113.7M modification (P00011) to contract 75N91025F00016 from the Department of Health and Human Services.
- The modification is for the NCI Operational Task Order, covering FY26-FY27.
- Action date is 2026-08-31.
- The award is a modification to an existing contract, indicating ongoing work and a strong agency relationship.
- Leidos's annual revenue is not available in the provided data, so revenue impact percentage cannot be calculated.
Financial Impact
$113.7M contract modification from HHS for NCI operational task order.
Risk Factors
- Government funding risk from continuing resolutions or budget sequestration.
- Execution risk on the operational task order.
- Political/regulatory risk from changes in HHS or NCI priorities.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 federal contract record from official U.S. government contract data.
| Document | Accession Number |
|---|---|
| GOVT-CONTRACT Data (Synthetic) | contract-75N91025F00016 |
Track record
38 reports on LDOS
5 of 6 bullish or bearish reports moved the stock their way by T+20. Best: +14.62% at T+20 after the Sep 29, 2026 report. 6 of 7 went positive at some point.
Filters
- Nov 2, 202614d ago 8-K Bullish 6/10 Entry $134.72 Now $130.02 −3.49% settles Dec 2
- Oct 30, 202617d ago Press Release Neutral 2/10 Entry $144.16 Now $130.02 −9.81% settles Dec 1
- Oct 23, 202624d ago Institutional Cluster Mixed 3/10 Entry $136.08 Now $130.02 −4.45% settles Nov 20
- Oct 14, 20264w ago Press Release Neutral 3/10 Entry $120.59 to $133.89 Now $130.02 +7.82% ▲ +11.03% +12.30% vs SPY
- Oct 13, 20265w ago GOVT-CONTRACT Neutral 3/10 Entry $120.59 to $133.89 Now $130.02 +7.82% ▲ +11.03% +12.30% vs SPY
- Oct 6, 20265w ago Press Release Neutral 1/10 Entry $116.69 Now $130.02 +11.42% No price data
- Oct 5, 20266w ago 8-K Neutral 5/10 Entry $119.45 to $142.98 Now $130.02 +8.85% ▲ +19.70% +22.16% vs SPY
- Oct 1, 20266w ago 8-K Neutral 2/10 Entry $121.97 to $141.02 Now $130.02 +6.60% ▲ +15.62% +14.92% vs SPY
- Oct 1, 20266w ago GOVT-CONTRACT Neutral 2/10 Entry $117.74 to $142.98 Now $130.02 +10.43% ▲ +21.44% +23.25% vs SPY
- Oct 1, 20266w ago GOVT-CONTRACT Neutral 3/10 Entry $117.74 to $142.98 Now $130.02 +10.43% ▲ +21.44% +23.25% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers